- Report
- February 2026
- 194 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 198 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 587 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 768 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 809 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- December 2025
- 210 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- December 2025
- 210 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- November 2025
- 210 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- November 2025
- 210 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- October 2025
- 190 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- September 2025
- 192 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- May 2025
- 225 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- November 2025
- 210 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- November 2025
- 210 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- November 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- September 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- August 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- March 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- January 2026
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 185 Pages
Global
From €3941EUR$4,500USD£3,421GBP

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more